Health Care [ 5/12 ] | Pharmaceuticals [ 13/73 ]
NASDAQ | Common Stock
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally.
It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.
The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers.
MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 14, 25 | -1.23 Decreased by -80.88% | -0.57 Decreased by -115.15% |
| May 27, 25 | -0.07 Increased by +93.33% | -0.66 Increased by +89.43% |
| Mar 19, 25 | -0.36 Decreased by -89.47% | -0.61 Increased by +40.74% |
| Nov 19, 24 | -0.98 Decreased by -308.33% | -0.44 Decreased by -122.73% |
| Aug 14, 24 | -0.68 Decreased by -780.00% | -0.42 Decreased by -61.90% |
| May 29, 24 | -1.05 Decreased by -138.64% | -0.41 Decreased by -156.10% |
| Mar 21, 24 | -0.19 Increased by +83.90% | -0.23 Increased by +17.39% |
| Nov 21, 23 | -0.24 Increased by +73.63% | -0.44 Increased by +45.45% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 5.71 M Increased by +12.74% | -13.32 M Decreased by -111.23% | Decreased by -233.32% Decreased by -87.36% |
| Mar 31, 25 | 3.96 M Decreased by -20.33% | -726.00 K Increased by +92.54% | Decreased by -18.36% Increased by +90.63% |
| Dec 31, 24 | 5.84 M Increased by +9.40% | -3.91 M Decreased by -124.21% | Decreased by -66.92% Decreased by -104.94% |
| Sep 30, 24 | 4.36 M Decreased by -8.81% | -10.28 M Decreased by -368.21% | Decreased by -236.10% Decreased by -413.48% |
| Jun 30, 24 | 5.06 M Increased by +6.08% | -6.30 M Decreased by -788.32% | Decreased by -124.53% Decreased by -748.89% |
| Mar 31, 24 | 4.96 M Increased by +30.67% | -9.73 M Decreased by -163.44% | Decreased by -195.99% Decreased by -101.62% |
| Dec 31, 23 | 5.34 M Decreased by -54.05% | -1.74 M Increased by +76.63% | Decreased by -32.65% Increased by +49.13% |
| Sep 30, 23 | 4.78 M Decreased by -17.70% | -2.20 M Increased by +47.70% | Decreased by -45.98% Increased by +36.46% |